|
1125-1245
|
Symposium 1A
Joint Symposium with Diabetic Medicine on cardiovascular risk factors
(Chairpersons: Professor Andrea Luk and Professor Nick Oliver)
Mitigating cardiovascular risk by physical activity and exercise - evidence and mechanisms
Professor Othmar Moser, Head of Department of Exercise Physiology and Metabolism, University of Bayreuth, Bayreuth, Germany
Atrial fibrillation and diabetes
Dr Mark Tam, Clinical Lecturer, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
New and emerging therapies for dyslipidemia
Professor Kathryn Tan, Sir David Todd Professor in Medicine, Department of Medicine, The University of Hong Kong, Hong Kong, China
|
Symposium 1B
Joint Symposium with The Nethersole School of Nursing, CUHK
(Chairpersons: Professor Helen Chan and Ms Kit-man Loo)
Sustainable primary healthcare system for chronic disease prevention and management
Dr Tony Ha, Assistant Commissioner for Primary Healthcare, Primary Healthcare Office, Health Bureau, The Government of the Hong Kong Special Administrative Region, Hong Kong, China
Lipohypertrophy
Ms Anna Chui, Advanced Practice Nurse, Diabetes Centre, Tseung Kwan O Hospital, Hospital Authority, Hong Kong, China
Diabetes in pregnancy
Dr Tiffany Yau, Honorary Clinical Associate Professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
|
|
1315-1415
|
Bayer Healthcare Lunch Symposium
(Chairperson: Dr Peter Tong)
New pillar of therapy for diabetic kidney disease: non-steroidal mineralocorticoid receptor antagonist
Professor Linong Ji, Professor of Medicine, Peking University, Beijing, China
|
AstraZeneca Hong Kong Lunch Symposium
(Chairperson: Professor Juliana Chan)
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
Professor Ralph DeFronzo, Professor of Medicine, University of Texas Health Science Center, San Antonio, Texas, USA
|
Roche Diagnostics (Hong Kong) Lunch Symposium
(Chairperson: Dr Jenny Leung)
Latest evidence on NT-proBNP and cardiovascular risk prediction in diabetes
Professor Ronald Ma, S H Ho Professor of Diabetes, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
|
|
|
1515-1635
|
Symposium 2A
Basic and translational science
(Chairpersons: Dr Connie Hui and Dr Xiaoyu Tian)
Advances in nanotherapeutics for atherosclerosis
Professor Jonathan Choi, Associate Professor, Department of Biomedical Engineering, Faculty of Engineering, The Chinese University of Hong Kong, Hong Kong, China
Disrupted lipid metabolism in obesity-related metabolic associated fatty liver disease
Dr Kenneth Cheng, Associate Professor, Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong, China
Therapeutic targets of metabolic disorders - what's new?
Dr Xavier Wong, Assistant Professor, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
|
Symposium 2B
Joint Symposium with The Hong Kong Geriatrics Society
(Chairpersons: Dr Doris Chan and Dr Stanley Tam)
Cognitive impairment in older adults with diabetes
Dr Roger Chen, Conjoint Professor, UNSW Medicine and Health, University of New South Wales, Sydney, Australia
Bladder dysfunction in elderly with diabetes
Dr William Wong, Associate Consultant, Department of Medicine and Geriatrics, Alice Ho Miu Ling Nethersole Hospital, Hospital Authority, Hong Kong, China
Machine learning model in preventing severe hypoglycemia in older adults with diabetes
Dr Elaine Chow, Assistant Professor, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
|